NIH
NIH to Hold Series of Listening Sessions on UNITE Initiative and Racial Equity
Throughout the end of 2021 and early 2022, the National Institutes of Health (NIH) will be holding a series of listening sessions to gather stakeholder feedback on achieving racial equity as part of the agency’s UNITE Initiative. The UNITE Initiative, which was launched by NIH in March 2021, is intended to analyze and address the agency’s practices to better foster diversity, equity, and inclusion in the biomedical research enterprise (see previous COSSA coverage for more details). A full list of the upcoming sessions and registration information is available here.
Cures 2.0 Bill Introduced in the House, Includes RISE Act and ARPA-H Authorization
On November 16, Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) introduced the Cures 2.0 Act, long anticipated legislation aiming to bolster the U.S. biomedical research enterprise. Most notably, the legislation would authorize $6.5 billion for an Advanced Research Projects Agency for Health (ARPA-H), a long-touted Biden Administration priority. Unlike the previously introduced Advanced Research Project Agency-Health (ARPA-H) Act (H.R. 5585) which authorizes $3 billion for an independent ARPA-H within the Department of Health and Human Services, the Cures 2.0 Act would establish ARPA-H within the National Institutes of Health (NIH) (see previous coverage for more details). In addition to…
NIH Holds Annual Behavioral and Social Science Research Festival
On November 18-19, the National Institutes of Health (NIH) Office of Behavioral and Social Sciences Research (OBSSR) held the 2021 Behavioral and Social Science Research Festival, an annual event designed to highlight the contributions of recently funded behavioral and social science projects to health research via presentations by extramural and NIH scientists from across the spectrum of disciplines. The two-day event was held virtually. The event hosted presentations on a variety of behavioral and social science topics, with heavy emphasis on health equity among minority populations, mental and cognitive health, and behavioral responses to the COVID-19 pandemic. This year’s festival…
NIH to Host 2021 Behavioral and Social Sciences Research Festival
On November 18 and 19, the National Institutes of Health (NIH) Office of Behavioral and Social Sciences Research (OBSSR) will host the 2021 NIH Behavioral and Social Sciences Research Festival. The virtual festival brings together researchers from around NIH and will feature four plenary sessions. Among other presenters, Director of the National Institute on Nursing Research (NINR) Shannon N. Zenk will serve as a keynote presenter and outgoing OBSSR Director Bill Riley will deliver remarks on “the State of Behavioral and Social Science Research at the NIH.” Registration details and more information about the festival may be found on the…
ARPA-H Authorization Bill Introduced in the House
On October 15, Representative Anna Eshoo (D-CA), Chairwoman of the Health Subcommittee within the House Committee on Energy and Commerce, introduced the Advanced Research Project Agency-Health (ARPA-H) Act (H.R. 5585), a bill authorizing the agency that has been a key priority in the Biden Administration’s budget for fiscal year (FY) 2022 (see previous coverage). Notably, the bill would not establish ARPA-H within the National Institutes of Health (NIH) as the White House and some appropriators in both chambers have proposed, but rather within the Department of Health and Human Services (HHS), setting up a potential conflict between appropriators and authorizers…
Bill Riley to Retire as Director of NIH Office of Behavioral and Social Sciences Research
On September 30, William T. Riley, Associate Director for Behavioral and Social Science Research (BSSR) at the National Institutes of Health (NIH) and Director of the Office of Behavioral and Social Sciences Research (OBSSR), announced his retirement from NIH at the end of December 2021. OBSSR Deputy Director Christine Hunter will take over as Acting Director position until a permanent replacement is named. Riley, who has led BSSR efforts at NIH for the past seven years, has been a tremendous proponent of the social and behavioral sciences through his previous roles at NIH including in the National Cancer Institute (NCI),…
October Headlines to Feature Deep Dive on Opportunities in the Basic Behavioral and Social Sciences at NIH with Outgoing OBSSR Director
COSSA members can sign up for our monthly Headlines webchat to catch up on the most important social and behavioral science news from the past month. October’s webinar will feature a deep dive discussion with Dr. William T. Riley, Director of the Office of Behavioral and Social Sciences Research (OBSSR) at the National Institutes of Health (NIH), who will share findings from the recent NIH Advisory Committee Working Group report, Trans-NIH Research Opportunities in the Basic Behavioral and Social Sciences. Individuals employed by or affiliated with a COSSA member organization can register for the webchat here.
Francis Collins Stepping Down as NIH Director
On October 5, Director of the National Institutes of Health (NIH) Francis Collins announced his intent to step down from his position by the end of the year. Collins has indicated he would continue to work at NIH within the National Human Genome Research Institute (NHGRI) after his tenure ends. Collins, who took the helm of the agency in 2009 after 15 years of service as the director of NHGRI, is notable for being the longest serving presidentially appointed NIH director and for serving presidents from both major parties. In addition, Collins oversaw massive increases in the agency’s budget over…
NIH Releases 2021-2025 Strategic Plan
The National Institutes of Health (NIH) has released its agency-wide Strategic Plan for fiscal years (FY) 2021-2025, a roadmap outlining key objectives and themes for the agency for the next five years. The plan organizes its strategy into three major objectives for the agency: Advancing Biomedical and Behavioral Sciences; Developing, Maintaining, and Renewing Scientific Research Capacity; and Exemplifying and Promoting the Highest Level of Scientific Integrity, Public Accountability, and Social Responsibility in the Conduct of Science. The Strategic Plan also outlines five cross-cutting themes that run through each of the three major objectives and all aspects of the agency’s strategy:…
NIH and OSTP to Hold Stakeholder Listening Sessions on ARPA-H Priorities
The National Institutes of Health (NIH) and the White House Office of Science and Technology Policy (OSTP) have announced the dates for a series of virtual listening sessions to receive feedback from scientific societies, patient advocacy groups, industry, and other stakeholders about potential projects and priorities for Advanced Research Projects Agency for Health (ARPA-H), the proposed new agency to be housed within NIH dedicated to high-risk, high-reward research applied to solve broad societal problems (see previous COSSA coverage for more details). The listening sessions, which will be broken up by topical focus, may include a variety of formats including large,…
NIAAA Requesting Input on 2022-2026 Strategic Plan Outline
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) within the National Institutes of Health (NIH) has issued a Request for Information inviting feedback from stakeholders on the outline of the upcoming NIAAA Strategic Plan for Fiscal Years (FY) 2022-2026. The strategic plan outline, which is included in the request, contains several cross-cutting themes including promoting health equity and diversity in alcohol research spaces, identifying unique risks for alcohol misuse, advancing research on co-occurring conditions with alcohol misuse, supporting new technologies on diagnosis of alcoholism, increasing the use of data science in alcohol research, and encouraging collaboration between alcohol research…
Eric Lander Active in First Few Weeks as OSTP Director; Community Awaits PCAST Appointments
In the first few weeks since his confirmation on May 28, Director of the White House Office of Science and Technology Policy (OSTP) Eric Lander has been active in advocating for President Biden’s ambitious science policy agenda, most notably the proposal for the Advanced Research Projects Agency for Health (ARPA-H), the DARPA-like research agency proposed to be housed within the National Institutes of Health (NIH). During the June 10-11 meeting of the Advisory Committee to the Director of NIH, Lander presented a more thorough vision of ARPA-H’s role as a high risk, high reward vehicle to address specific societal questions….
House and Senate Appropriators Hold Hearings on NIH Budget for FY 2022
The Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies (LHHS) in both the House and the Senate recently held hearings to discuss the fiscal year (FY) 2022 budget for the National Institutes of Health (NIH). Since both hearings were held prior to the full release of President Biden’s FY 2022 budget request, much of the discussion focused on the proposed increase to the top-line budget for NIH as well as the proposal for a new Advanced Research Projects Agency for Health (ARPA-H) as referenced in the Biden Administration’s “skinny budget” released earlier this year. The House…
NIH Working Group Presents Report on Opportunities in Basic Behavioral and Social Science Research
During the May 20-21 meeting of the Council of Councils at the National Institutes of Health (NIH), a Working Group on Basic Behavioral and Social Science Research (bBSSR) presented a report analyzing past support for basic research on behavioral and social phenomena related to health and areas ripe for additional study. The working group report, co-chaired by the Director of NIH’s Office of Behavioral and Social Sciences Research (OBSSR) Dr. Bill Riley, looks at the historical trends of basic research at NIH and identifies potential trans-NIH opportunities to fill gaps in the agency’s efforts. The presentation touched on several trends…
NIH Launches New Bridge2AI Program
The National Institutes of Health (NIH) Common Fund has established a new program, Bridge to Artificial Intelligence (Bridge2AI), which aims to generate flagship data sets and best practices for the collection and preparation of Artificial Intelligence (AI)/Machine Learning (ML)-ready data to address biomedical and behavioral research grand challenges. The program plans to support several interdisciplinary Data Generation Projects (OTA-21-008) and one complementary cross-cutting Integration, Dissemination and Evaluation (BRIDGE) Center (NOT-RM-21-021). The new program was the subject of a recent post on the National Library of Medicine (NLM) Director’s blog. NIH will also host a series of webinars and virtual events in June to share more information about…
ECHO Program Seeks Comments on Collecting Pre-Conception Data
The National Institutes of Health (NIH) has issued a request for information (RFI) on improving the science of the Environmental influences on Child Health Outcomes (ECHO) program (see COSSA’s previous coverage). NIH is interested in input from the external community on topics including (but not limited to) enhancing the program’s study origins of child health outcomes originating prior to conception, as well as more general strategies for maintaining scientific value while reducing the burden of primary data collection on participants and staff, addressing public health emergencies, enhancing recruitment and retention of diverse populations, and promoting diversity of the workforce related…
Biden Preliminary FY 2022 R&D Proposals Rely on “DARPA” Model
On April 9, the Biden Administration released preliminary, high-level details of its fiscal year (FY) 2022 budget request, referred to as a “skinny budget.” At this stage, details are only available for Cabinet-level departments and a handful of other “major” agencies, with limited details about some agencies within the departments. For example, it includes preliminary details for the National Institutes of Health (NIH), but not for the Census Bureau. Full budget details will be released in the coming months. In the meantime, however, Congress is proceeding with the FY 2022 appropriations process without the Administration’s full proposals. Appropriators in both…
NIH Releases Minority Health and Health Disparities Strategic Plan for 2021-2025
The National Institute on Minority Health and Health Disparities (NIMHD) within the National Institutes of Health (NIH) has released its strategic plan for 2021 through 2025 to advance minority health and health disparities research across all NIH institutes, offices, and centers. The strategic plan, which was developed with input across the NIH and the minority health and health disparity research community, lays out goals and strategies for the agency to advance additional scientific research, support research-adjacent activities, and expand outreach and strategic communications on minority health and health disparities. These goals and strategies include: Promoting research to understand and improve…
NIH Presents Report on Racism in Science, Launches UNITE Initiative to End Structural Racism in Biomedical Research
During a meeting of the National Institutes of Health (NIH) Advisory Committee to the Director (ACD) on February 26, 2021, NIH discussed new and ongoing efforts to eliminate agency structures perpetuating racism in the biomedical research enterprise. During the meeting, the ACD’s Working Group on Diversity (WGD) presented its Report on Racism in Science, a document that had been in development throughout the past year in the wake of nationwide protests condemning White supremacy and racial inequity, especially as it affects Black members of the scientific community. The WGD report presents several strategies and recommendations for the ACD to consider…
Lawmakers Reintroduce RISE Act
On February 5, a bipartisan group of lawmakers reintroduced the Research Investment to Spark the Economy (RISE) Act. As previously reported, the RISE Act seeks to provide funding relief to federal science agencies impacted by the COVID-19 pandemic. The bill would authorize $25 billion in emergency relief, including $10 billion for the National Institutes of Health and $3 billion for the National Science Foundation. Funding would be used to support non-COVID-related research that has been impacted or shuttered by the closure of labs resulting from the pandemic. This legislation is different from the $1.9 trillion COVID package discussed elsewhere in…